976 related articles for article (PubMed ID: 6138364)
21. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
Wägar G; Mäkinen T; Lamberg BA; Gordin A; Apter L; Pekonen F
Ann Clin Res; 1982 Apr; 14(2):83-9. PubMed ID: 6184007
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic value of thyroid antibodies].
Toldy E; Lócsei Z; Kalmár I; Varga L; Kovács LG
Orv Hetil; 1996 Sep; 137(38):2075-80. PubMed ID: 8966023
[TBL] [Abstract][Full Text] [Related]
23. Photoaffinity labelling of the porcine thyrotropin receptor--effect of Graves' immunoglobulin G and anti-TSH anti-idiotypic antibodies.
Bakó G; Islam MN; Farid NR
Clin Invest Med; 1985; 8(2):152-9. PubMed ID: 2870832
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of immunogenic regions in TSH receptor for Graves' IgG and Hashimoto's IgG].
Murakami M; Miyashita K; Mori M
Nihon Rinsho; 1994 Apr; 52(4):1057-62. PubMed ID: 8196164
[TBL] [Abstract][Full Text] [Related]
25. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
Loeffler M; Zakarija M; McKenzie JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
[TBL] [Abstract][Full Text] [Related]
26. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
Strakosch CR; Joyner D; Manley SW; Wall JR
Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
[TBL] [Abstract][Full Text] [Related]
27. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M
Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
[TBL] [Abstract][Full Text] [Related]
28. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
Baker JR; Saunders NB; Kaulfersch W; Burman KD
J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
[TBL] [Abstract][Full Text] [Related]
29. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
30. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
31. Binding of immunoglobulin G from patients with autoimmune thyroid diseases to solubilized guinea pig fat cell membranes crosslinked with 125I-TSH.
Iida Y; Konishi J; Misaki T; Kasagi K; Endo K; Kuma K; Torizuka K
Endocrinol Jpn; 1986 Jun; 33(3):333-43. PubMed ID: 2428605
[TBL] [Abstract][Full Text] [Related]
32. Immunoprecipitation of TSH-TSH receptor complexes.
Parkes AB; Kajita Y; Buckland PR; Howells RD; Rickards CR; Creagh FM; Rees Smith B
Clin Endocrinol (Oxf); 1985 Apr; 22(4):511-20. PubMed ID: 2985304
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
34. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
35. A non-isotopic screening test for antibodies to TSH receptor: dot immunobinding assay.
Bakó G; Islam MN; Vértes M; Lenkey A; Farid NR; Leövey A
Acta Med Hung; 1989; 46(2-3):121-31. PubMed ID: 2812956
[TBL] [Abstract][Full Text] [Related]
36. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
37. Elisa for the measurement of complement C3 activation by autoantibodies directed against thyroid membrane antigens.
Parkes AB; Harris R; Williams S; Lazarus JH; Waters JS
J Clin Lab Immunol; 1991 Jul; 35(3):139-45. PubMed ID: 1668767
[TBL] [Abstract][Full Text] [Related]
38. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
39. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
40. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
